Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wegener's granulomatosis

G F Duna1, C Galperin, G S Hoffman

  • 1Cleveland Clinic Foundation, Ohio, USA.

Rheumatic Diseases Clinics of North America
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis.

Clinical and experimental immunology·2017
Same author

Establishing the Feasibility of Face Transplantation in Granulomatosis With Polyangiitis.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Giant cell arteritis: Commentary on recommendations of the French Study Group for Large Vessel Vasculitis (GEFA).

La Revue de medecine interne·2016
Same author

Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.

Arthritis & rheumatology (Hoboken, N.J.)·2015
Same author

Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis.

Arthritis & rheumatology (Hoboken, N.J.)·2014
Same author

Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.

Arthritis and rheumatism·2013
Same journal

Rheumatology at the Threshold of Artificial Intelligence.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence Regulation in the United States: Current Landscape and Implications for Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

The Role of Artificial Intelligence in Medical Education and Training: Implications for Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Sources of Bias in Clinical Artificial Intelligence and Applications in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Toward Bridging the Gap from Artificial Intelligence in Clinical Research to Clinical Practice in Rheumatology: The Mayo Experience.

Rheumatic diseases clinics of North America·2026
See all related articles

Effective management of Wegener's granulomatosis (WG) requires prompt diagnosis, monitoring of disease activity, and anticipation of potential complications. This approach ensures optimal patient outcomes for this rare autoimmune condition.

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • Wegener's granulomatosis (WG), a rare autoimmune vasculitis, presents with diverse clinical manifestations.
  • Timely diagnosis and management are crucial for preventing severe organ damage.

Purpose of the Study:

  • To outline a comprehensive clinical approach for the effective management of Wegener's granulomatosis.
  • To highlight key considerations for diagnosis, monitoring, and complication management in WG.

Main Methods:

  • This study focuses on a strategic approach to patient care.
  • Key elements include diagnostic criteria, disease activity assessment, and morbidity prediction.

Main Results:

  • Prompt diagnosis is essential for initiating appropriate treatment.

Related Experiment Videos

  • Continuous monitoring of disease activity and potential morbidities is critical.
  • Anticipating treatment-related side effects improves patient safety and adherence.

    • Conclusions:

    • An integrated approach encompassing early diagnosis, vigilant monitoring, and proactive management of complications is vital for effectively treating Wegener's granulomatosis.
    • This strategy aims to improve patient prognosis and quality of life.